Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220700855> ?p ?o ?g. }
- W4220700855 endingPage "799" @default.
- W4220700855 startingPage "792" @default.
- W4220700855 abstract "BackgroundMany individuals with cystic fibrosis (CF) have chronic rhinosinusitis resulting in nasal obstruction, sinus infections, and repeated surgeries. Elexacaftor-tezacaftor-ivacaftor is a highly effective modulator therapy approved for individuals aged 6 years or older with CF who have at least one F508del allele or other responsive mutation. The current study tests the hypothesis that ELX/TEZ/IVA improves sinonasal disease in CF.MethodsThe study was a pre/post, observational cohort study conducted at two sites. Participants underwent a study visit prior to starting ELX/TEZ/IVA and a second visit at a median of 9 months on therapy. Each visit included sinus CT scan, rigid nasal endoscopy, and sweat chloride measurement. Symptoms were measured with the 22 item Sinonasal Outcome Test at scheduled intervals during the study. Regression models were used to test for improvement in symptoms, endoscopy, and CT scales.ResultsThe study enrolled 34 individuals, with a median age of 27 years (range 12–60). Symptoms improved within 7 days of therapy and plateaued by day 28. Endoscopic crusting resolved and nasal polyposis improved, with a decrease in size or resolution of polyps. Sinus opacification and mucosal thickening improved on CT radiographs with treatment.ConclusionsSinonasal symptoms improved rapidly and durably for at least 180 days on ELX/TEZ/IVA therapy. Objective measures of disease including endoscopic and CT findings improved with ELX/TEZ/IVA." @default.
- W4220700855 created "2022-04-03" @default.
- W4220700855 creator A5002667632 @default.
- W4220700855 creator A5002960800 @default.
- W4220700855 creator A5007122099 @default.
- W4220700855 creator A5024297859 @default.
- W4220700855 creator A5034939524 @default.
- W4220700855 creator A5042997375 @default.
- W4220700855 creator A5054478039 @default.
- W4220700855 creator A5061689322 @default.
- W4220700855 creator A5067211665 @default.
- W4220700855 creator A5072790450 @default.
- W4220700855 date "2022-09-01" @default.
- W4220700855 modified "2023-10-15" @default.
- W4220700855 title "Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis" @default.
- W4220700855 cites W119806249 @default.
- W4220700855 cites W1509342485 @default.
- W4220700855 cites W1937134345 @default.
- W4220700855 cites W1951112599 @default.
- W4220700855 cites W1968388114 @default.
- W4220700855 cites W2030674948 @default.
- W4220700855 cites W2070011856 @default.
- W4220700855 cites W2080802372 @default.
- W4220700855 cites W2081573208 @default.
- W4220700855 cites W2092552824 @default.
- W4220700855 cites W2093274439 @default.
- W4220700855 cites W2095804373 @default.
- W4220700855 cites W2101279286 @default.
- W4220700855 cites W2139140708 @default.
- W4220700855 cites W2162681613 @default.
- W4220700855 cites W2345551155 @default.
- W4220700855 cites W2405233220 @default.
- W4220700855 cites W2559378310 @default.
- W4220700855 cites W2564362350 @default.
- W4220700855 cites W2774107573 @default.
- W4220700855 cites W2793898214 @default.
- W4220700855 cites W2901113760 @default.
- W4220700855 cites W2903920902 @default.
- W4220700855 cites W2917538474 @default.
- W4220700855 cites W2946590475 @default.
- W4220700855 cites W2948929092 @default.
- W4220700855 cites W2995941010 @default.
- W4220700855 cites W3003144305 @default.
- W4220700855 cites W3034912352 @default.
- W4220700855 cites W3042636757 @default.
- W4220700855 cites W3203804821 @default.
- W4220700855 cites W3209666953 @default.
- W4220700855 cites W4225990591 @default.
- W4220700855 cites W2412376293 @default.
- W4220700855 doi "https://doi.org/10.1016/j.jcf.2022.03.002" @default.
- W4220700855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35300931" @default.
- W4220700855 hasPublicationYear "2022" @default.
- W4220700855 type Work @default.
- W4220700855 citedByCount "25" @default.
- W4220700855 countsByYear W42207008552022 @default.
- W4220700855 countsByYear W42207008552023 @default.
- W4220700855 crossrefType "journal-article" @default.
- W4220700855 hasAuthorship W4220700855A5002667632 @default.
- W4220700855 hasAuthorship W4220700855A5002960800 @default.
- W4220700855 hasAuthorship W4220700855A5007122099 @default.
- W4220700855 hasAuthorship W4220700855A5024297859 @default.
- W4220700855 hasAuthorship W4220700855A5034939524 @default.
- W4220700855 hasAuthorship W4220700855A5042997375 @default.
- W4220700855 hasAuthorship W4220700855A5054478039 @default.
- W4220700855 hasAuthorship W4220700855A5061689322 @default.
- W4220700855 hasAuthorship W4220700855A5067211665 @default.
- W4220700855 hasAuthorship W4220700855A5072790450 @default.
- W4220700855 hasBestOaLocation W42207008551 @default.
- W4220700855 hasConcept C126322002 @default.
- W4220700855 hasConcept C126838900 @default.
- W4220700855 hasConcept C157369684 @default.
- W4220700855 hasConcept C2776407911 @default.
- W4220700855 hasConcept C2776502428 @default.
- W4220700855 hasConcept C2776938444 @default.
- W4220700855 hasConcept C2778428886 @default.
- W4220700855 hasConcept C2778451229 @default.
- W4220700855 hasConcept C2779879311 @default.
- W4220700855 hasConcept C2781390199 @default.
- W4220700855 hasConcept C59822182 @default.
- W4220700855 hasConcept C71924100 @default.
- W4220700855 hasConcept C72563966 @default.
- W4220700855 hasConcept C86803240 @default.
- W4220700855 hasConcept C90924648 @default.
- W4220700855 hasConceptScore W4220700855C126322002 @default.
- W4220700855 hasConceptScore W4220700855C126838900 @default.
- W4220700855 hasConceptScore W4220700855C157369684 @default.
- W4220700855 hasConceptScore W4220700855C2776407911 @default.
- W4220700855 hasConceptScore W4220700855C2776502428 @default.
- W4220700855 hasConceptScore W4220700855C2776938444 @default.
- W4220700855 hasConceptScore W4220700855C2778428886 @default.
- W4220700855 hasConceptScore W4220700855C2778451229 @default.
- W4220700855 hasConceptScore W4220700855C2779879311 @default.
- W4220700855 hasConceptScore W4220700855C2781390199 @default.
- W4220700855 hasConceptScore W4220700855C59822182 @default.
- W4220700855 hasConceptScore W4220700855C71924100 @default.
- W4220700855 hasConceptScore W4220700855C72563966 @default.
- W4220700855 hasConceptScore W4220700855C86803240 @default.
- W4220700855 hasConceptScore W4220700855C90924648 @default.